No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological* / adverse effects
-
Humans
-
Ischemia / chemically induced
-
Ischemia / diagnosis
-
Melanoma* / drug therapy
-
Nivolumab / adverse effects
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab